The Creighton Model FertilityCare System (CrMS) is introduced as a standardized, scientifically grounded method for observing and recording cervical mucus biomarkers and bleeding patterns across the menstrual cycle. Its development from earlier natural family planning methods into a fully systematized fertility monitoring tool is traced, establishing the CrMS as the observational substrate for all subsequent NaProTECHNOLOGY medical applications.
what is the Creighton Model FertilityCare System, difference between Creighton Model and Billings Ovulation Method, how does the Creighton Model relate to NaProTechnology, what is the Peak Day in fertility charting, is the Creighton Model a form of contraception, how to become a FertilityCare Practitioner, can you chart fertility while breastfeeding or coming off the pill, what is a base infertile pattern in fertility charting
Cite this article
Hilgers, T. W. (2004). Chapter 4: Introduction to the CREIGHTON MODEL System. The Medical and Surgical Practice of NaProTECHNOLOGY, 87-102.
Hilgers TW. Chapter 4: Introduction to the CREIGHTON MODEL System. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:87-102.
Hilgers, T. W. "Chapter 4: Introduction to the CREIGHTON MODEL System." The Medical and Surgical Practice of NaProTECHNOLOGY, 2004, pp. 87-102.
Related articles
Fertility AwarenessCreighton Model FertilityCare SystemCervical Mucus BiomarkersPeak Day Identification
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The content and sequence of the introductory and follow-up instructional sessions that constitute the formal CrMS education series are outlined, covering observation technique, recording conventions, and the practitioner-client interaction model. Consistent delivery of these core instructions establishes the behavioral competence required for both family planning use and the medical monitoring applications that NaProTECHNOLOGY depends upon.
NaProTECHNOLOGYCreighton Model FertilityCare SystemCervical eversion and ectropionChronic discharge charting and classification
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The Creighton Model's standardized daily vulvar observation system -- recording discharge color, consistency, quantity, and sensation -- allows chronic pathological discharges (persistent yellow or cloudy mucus, continuous post-Peak discharge, premenstrual brown bleeding, or refractory vulvovaginitis) to be distinguished from normal cyclical mucus patterns and tracked longitudinally as a diagnostic tool. NaProTECHNOLOGY uses chronic discharge patterns as biomarkers that prompt organism-specific cultures, targeted hormonal evaluation, ultrasound, and etiology-directed treatment -- including antimicrobials, cooperative hormone replacement, or fertility-sparing surgery -- rather than empirical cycle suppression.
Fertility AwarenessCreighton Model FertilityCare SystemAchieving-Related Pregnancy RateDemographic Effectiveness Research
Hilgers TW et al., 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Pregnancy achievement rates among couples using the CrMS to target fertile days are analyzed by cycle type, reproductive history, and duration of use, demonstrating the system's capacity to accommodate irregular and abnormal cycles without reducing its fertility-targeting utility. These data are foundational to NaProTECHNOLOGY's application in infertility management, establishing that the CrMS identifies fertile windows even in subfertile populations with disrupted cycle parameters.
Fertility AwarenessCreighton Model FertilityCare SystemContinuous Mucus DischargeEssential Sameness Pattern and Point of Change
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Women with persistent or continuous vaginal discharges — including those from chronic cervicitis, hormonal imbalance, or other gynecologic sources — present a distinct charting challenge, and this chapter provides CrMS-specific protocols for distinguishing pathologic discharge from fertile-quality cervical mucus. Correct identification is clinically critical because misclassification distorts cycle interpretation, effectiveness calculations, and the hormone-assessment timeline.